After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Its architect's daughter has cystic fibrosis—and benefits from a "miracle drug" backed by an agency he's attacking.

For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...

To meet exacting specs for ultra-thin GRIN lenses, Peak Nano turned to ABTech for a groundbreaking system that delivered ...

with “clinically meaningful” improvements on that measure across both studies. Pain relief typically kicked in within two to four hours, according to Vertex, and VX-540 was also associated ...

Bernstein SocGen Group adjusted its price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), increasing it slightly from $441.00 to $444.00 while maintaining a Market Perform rating. With a ...

New York City Mayor Eric Adams is expected to meet with Director of Immigration and Customs Enforcement this week. As CBS ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

focused on the development of "hypoimmune" stem cells that are designed to evade the immune system of the patient and prevent rejection of the transplant. Vertex said VX-880 has already generated ...

U.S. stocks started lower on Tuesday as investors await Fed Chair Powell's remarks about the economy, tariffs, inflation and ...

Showcase your company news with guaranteed exposure both in print and online 25 years ago, Denver's economy thrived on IT, real estate & oil. DBJ will kick… Be Inspired! Meet Your Mentor! Make ...

Walmart sells millions of dollars worth of groceries a year. Sometimes, things go wrong. These are the biggest food recalls ...